Califf Plans US FDA, NIH Collaboration On Postmarket Evidence Generation - Pink Sheet
US Food and Drug Administration Commissioner Robert Califf’s evidence generation enhancement plans will include the National Institutes of Health, assuming that agency’s new leader takes office.